insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog]

Drug interactions

Insulin aspart-szjj may interact with various drugs that can either increase the risk of hypoglycemia or decrease its blood glucose lowering effect.

• moderateantidiabetic agents — may increase the risk of hypoglycemia
• moderateACE inhibitors — may increase the risk of hypoglycemia
• moderateangiotensin II receptor blocking agents — may increase the risk of hypoglycemia
• moderatedisopyramide — may increase the risk of hypoglycemia
• moderatefibrates — may increase the risk of hypoglycemia
• moderatefluoxetine — may increase the risk of hypoglycemia
• moderatemonoamine oxidase inhibitors — may increase the risk of hypoglycemia
• moderatepentoxifylline — may increase the risk of hypoglycemia
• moderatepramlintide — may increase the risk of hypoglycemia
• moderatesalicylates — may increase the risk of hypoglycemia
• moderatesomatostatin analog (e.g., octreotide) — may increase the risk of hypoglycemia
• moderatesulfonamide antibiotics — may increase the risk of hypoglycemia
• moderateatypical antipsychotics (e.g., olanzapine and clozapine) — may decrease the blood glucose lowering effect
• moderatecorticosteroids — may decrease the blood glucose lowering effect
• moderatedanazol — may decrease the blood glucose lowering effect
• moderatediuretics — may decrease the blood glucose lowering effect
• moderateestrogens — may decrease the blood glucose lowering effect
• moderateglucagon — may decrease the blood glucose lowering effect
• moderateisoniazid — may decrease the blood glucose lowering effect
• moderateniacin — may decrease the blood glucose lowering effect
• moderateoral contraceptives — may decrease the blood glucose lowering effect
• moderatephenothiazines — may decrease the blood glucose lowering effect
• moderateprogestogens (e.g., in oral contraceptives) — may decrease the blood glucose lowering effect
• moderateprotease inhibitors — may decrease the blood glucose lowering effect
• moderatesomatropin — may decrease the blood glucose lowering effect
• moderatesympathomimetic agents (e.g., albuterol, epinephrine, terbutaline) — may decrease the blood glucose lowering effect
• moderatethyroid hormones — may decrease the blood glucose lowering effect
• moderatealcohol — may increase or decrease the blood glucose lowering effect
• moderatebeta-blockers — may increase or decrease the blood glucose lowering effect and may blunt signs and symptoms of hypoglycemia
• moderateclonidine — may increase or decrease the blood glucose lowering effect and may blunt signs and symptoms of hypoglycemia
• moderatelithium salts — may increase or decrease the blood glucose lowering effect
• unknownpentamidine — may cause hypoglycemia followed by hyperglycemia
• unknownguanethidine — may blunt signs and symptoms of hypoglycemia
• unknownreserpine — may blunt signs and symptoms of hypoglycemia